Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Accumulated Expenses (2020 - 2025)

Bio Essence (BIOE) has 6 years of Accumulated Expenses data on record, last reported at $2287.0 in Q1 2025.

  • For Q1 2025, Accumulated Expenses fell 3.05% year-over-year to $2287.0; the TTM value through Mar 2025 reached $2287.0, down 3.05%, while the annual FY2024 figure was $2306.0, 2.99% down from the prior year.
  • Accumulated Expenses reached $2287.0 in Q1 2025 per BIOE's latest filing, down from $2306.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $16805.0 in Q1 2023 and bottomed at $2287.0 in Q1 2025.
  • Average Accumulated Expenses over 5 years is $8432.5, with a median of $6812.0 recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: soared 175.4% in 2021, then crashed 86.01% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $13054.0 in 2021, then plummeted by 48.25% to $6756.0 in 2022, then tumbled by 64.82% to $2377.0 in 2023, then fell by 2.99% to $2306.0 in 2024, then fell by 0.82% to $2287.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $2287.0 in Q1 2025, $2306.0 in Q4 2024, and $2324.0 in Q3 2024.